New Valeant Pharmaceuticals Intl Inc Board Sends Message As Firm Reinstates EarningsMark Melin
The day after what was described as “the most brutal” Senate grilling of a corporate executives in memory, a beat-down involving Valeant Pharmaceuticals, the company restated earnings and materially re-shuffled the board of directors. While the restatement was material, it was the new board members focused on fraud and medical issues that points to the future. For investors, the question going forward is likely to have . . .
This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here
If you are subscribed and having an account error please clear cache and then cookies if that does not work email firstname.lastname@example.org and we will get back to you as quick as humanly possible